GILD vs VC · P/E 18, rev $29.44B vs P/E 18, rev $3.87B
Gilead Sciences Inc (GILD) versus Visteon Corp (VC) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Visteon Corp (VC) is a auto parts company listed on NASDAQ.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported VC revenue for 2024-12-31 was $3.87B. Net income was $284.0M. Revenue was down 2.2% from 2023-12-31 to 2024-12-31. VC currently screens at market cap $2.95B and trailing P/E 18.5.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. VC currently screens at market cap $2.95B and trailing P/E 18.5.
Not investment advice. Open the GILD and VC stock pages for the full models.
Not investment advice.